Investing.com - Financial Markets Worldwide
👀 Copy Legendary Investors' Portfolios in One ClickCopy For Free

London stocks rise on optimism around virus drug, upbeat earnings

Published 04/30/2020, 03:13 PM
Updated 04/30/2020, 03:20 PM
© Reuters.
UK100
-
SHEL
-
GILD
-
RKT
-
FTMC
-
FTNMX402020
-

(For a live blog on European stocks, type LIVE/ in an Eikon
news window)
* FTSE 100 up 0.3%, FTSE 250 up 0.6%

April 30 (Reuters) - UK stock markets rose on Thursday as
investors cheered signs of progress in developing a treatment
for the novel coronavirus, while Reckitt Benckiser surged after
reporting strong demand for its products ahead of the lockdown.
The consumer goods firm RB.L said sales of its Lysol
disinfectants, Mucinex cough syrup and Dettol soap had jumped in
the first quarter and that it now expected performance in 2020
to be better than initially forecast. Its shares rose 3.2%,
pushing up the household goods index .FTNMX3720 2.3%.
The blue-chip FTSE 100 .FTSE rose 0.3%, climbing for the
fourth straight session and on track to post its biggest monthly
gain since 2011, with investors betting on a recovery in
business activity as economies start emerging from shutdowns
imposed to contain the coronavirus.
The domestically focussed mid-cap index .FTMC added 0.6%.
Positive partial results from a trial of U.S.-based Gilead
Sciences Inc's GILD.O remdesivir in speeding up recovery from
the disease also added to global optimism on Thursday.
MKTS/GLOB
On the other hand, Royal Dutch Shell RDSa.L fell 2.8% as
it cut its dividend for the first time in 80 years and suspended
the next tranche of its stock buyback programme.

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.